Description
Semaglutide (Wegovy) is an FDA-approved GLP-1 receptor agonist used for chronic weight management and type 2 diabetes support. By mimicking natural gut hormones, it reduces appetite, slows digestion, and supports sustainable fat loss. Clinical studies show that Wegovy can help patients achieve significant long-term weight reduction when combined with healthy lifestyle changes.
Key Benefits of Semaglutide (Wegovy):
Clinically proven to promote weight loss
FDA-approved for obesity and type 2 diabetes care
Helps control appetite and reduce calorie intake
Improves metabolic health and reduces risk factors
Convenient once-weekly injectable treatment
Why Choose Wegovy:
Trusted and widely prescribed weight loss solution
Backed by clinical research and FDA approval
Professional-grade injectable with consistent results
| Property | Details |
|---|---|
| Product Name | Semaglutide (Wegovy) |
| Form | Prefilled injectable pen |
| Type | GLP-1 receptor agonist |
| Strength | Commonly available in 0.25mg, 0.5mg, 1mg, 1.7mg, or 2.4mg per injection (check packaging) |
| Quantity | Varies depending on pack size (pens per box) |
| Usage | Supports weight management and blood sugar control in type 2 diabetes* |
| Suitable For | Adults (as directed by healthcare professional) |
| Shelf Life | Typically 2 years (check packaging) |
| Storage | Refrigerate at 2–8°C; do not freeze |
| Packaging | Prefilled disposable injection pens |
Reviews
There are no reviews yet.